(Q36734579)

English

Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence

scientific article published on September 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

0 references

0 references

Elena Verbitskaya

object named as

Elena Verbitskaya

4

0 references

author name string

Evgeny Krupitsky

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Edwin Zvartau

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Elena Blokhina

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Valentina Wahlgren

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Marina Tsoy-Podosenin

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Natalia Bushara

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Andrey Burakov

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Dmitry Masalov

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Tatyana Romanova

10

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Arina Tyurina

11

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Vladimir Palatkin

12

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Tatyana Slavina

13

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Anna Pecoraro

14

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

George E Woody

15

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

0 references

publication date

1 September 2012

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

JAMA Psychiatry

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

69

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

973-981

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Oral naltrexone maintenance treatment for opioid dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

Sustained-Release Naltrexone For Opioid Dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

Pharmacologic treatments for opioid dependence: detoxification and maintenance options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

Co-morbidity of infectious and addictive diseases in St. Petersburg and the Leningrad Region, Russia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

An Inventory for Measuring Depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

Drug abuse treatment as AIDS prevention.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

New data from the Addiction Severity Index. Reliability and validity in three centers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

Scales for physical and social anhedonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

30 September 2017

Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

28 June 2018

Naltrexone pharmacotherapy for opioid dependent federal probationers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

28 June 2018

Preparations for AIDS vaccine trials. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

28 June 2018

Nontolerance to the opioid antagonism of naltrexone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

28 June 2018

Injectable extended-release naltrexone for opioid dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

5 September 2018

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

5 September 2018

Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

5 September 2018

Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

5 September 2018

Overcoming opioid blockade from depot naltrexone (Prodetoxon).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

5 September 2018

Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

5 September 2018

Behavioral family counseling and naltrexone for male opioid-dependent patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

5 September 2018

The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methods.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614358

5 September 2018

Naltrexone for heroin dependence treatment in St. Petersburg, Russia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22945623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood naltrexone levels over time following naltrexone implant

1 reference

https://pubmed.ncbi.nlm.nih.gov/22945623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing

1 reference

https://pubmed.ncbi.nlm.nih.gov/22945623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/ARCHGENPSYCHIATRY.2012.1A

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36734579&oldid=1773285612"